New injection aims to tame Ultra-High cholesterol in rare genetic disorder
Disease control
Recruiting now
This study is testing an investigational injection called EDP167 in adults with a rare, severe genetic condition that causes extremely high cholesterol from birth. The goal is to see if the injections can safely lower 'bad' cholesterol (LDL-C) levels over 24 weeks. Participants w…
Phase: PHASE2 • Sponsor: Eddingpharm (Zhuhai) Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC